Antibody Protein ELISA Kit from MyBioSource header Telephone 1.858.633.0165          
Fax 1.858.633.0166    Email 
menu1 Home Products Ordering Company Help menu7
   MyBioSource  rightarrow Blog  rightarrow TRAT1 sirna  rightarrow LOG IN  rightarrow MY ACCOUNT  rightarrow CART CONTENTS  rightarrow CHECKOUT 
horiz bar
MyBioSource Blogs moreseparator
 • ALOX12 blocking peptide blog
 • anti-ABL1 antibody blog
 • anti-EGFR antibody blog
 • anti-ALB antibody blog
 • CRP blocking peptide blog
 • LMO3 sirna blog
 • TP53 blocking peptide blog
 • TMEM38B sirna blog
 • Epstein Barr IgA elisa kit blog
 • Goat Anti-Chicken IgG (H+L) secondary antibody blog
 • anti-CCL3L1 antibody blog
 • anti-SLC39A7 antibody blog
 • ALB recombinant protein blog
 • anti-BCAS3 antibody blog
 • anti-EGFR antibody blog
 • PEG3 sirna blog
 • TTC9C sirna blog
 • ASIC4 blocking peptide blog
 • anti-Akt antibody blog
 • C4orf33 sirna blog
Blog Categories separator
 • Assay Kit Blogs
 • Biochemical Blogs
 • cDNA Clone Blogs
 • Monoclonal Antibody Blogs
 • Polyclonal Antibody Blogs
 • Rec/Purified Protein Blogs
 • Popular Product Blogs
Our Best Sellers moreseparator
 • Keratin 5 (KRT5) Antibody
 • A Disintegrin and Metalloproteinase With Thrombospondin 1 (A... ELISA Kit
 • chromosome 6 open reading frame 26 (C6orf26) ELISA Kit
 • Ptx2, PITX2 Antibody
 • Ubiquilin-2 (Ubqln2) ELISA Kit
 • ICAM5 precursor Antibody
 • Guanine nucleotide-binding protein subunit alpha-13 (Gna13) Recombinant Protein
 • PYGL Antibody
 • ATP-Citrate Lyase (ACLY) Antibody
 • b-Amyloid Precursor Protein Antibody
 • 2900041A09RIK Antibody
 • Pyruvate Dehydrogenase Kinase Isozyme 1 (PDK1) Recombinant Protein
 • T lymphocyte subpopulation CD3-4-8 (TLS) ELISA Kit
 downarrow more ...

TRAT1 sirna product blog

Posted on 2017-11-24 22:48:58 by mybiosource_staff
Share it on ...     
Tags: TRAT1; siRNA; TRAT1 sirna;
The TRAT1 trat1 (Catalog #MBS8205207) is a siRNA produced from Synthetic and is intended for research purposes only. The product is available for immediate purchase. The TRAT1 siRNA (Human) reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s TRAT1 can be used in a range of immunoassay formats including, but not limited to, RNA Interference (RNAi). Researchers should empirically determine the suitability of the TRAT1 trat1 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.

The TRAT1 trat1 product has the following accession number(s) (GI #54607137) (NCBI Accession #NP_057472.2) (Uniprot Accession #Q6PIZ9). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.

To buy or view more detailed product information and pricing, please click on the technical datasheet page below:

siRNA to inhibit TRAT1 expression using RNA interference.

TRAT1 trat1

Quality Control: Oligonucleotide synthesis is monitored base by base through trityl analysis to ensure appropriate coupling efficiency. The oligo is subsequently purified by affinity-solid phase extraction. The annealed RNA duplex is further analyzed by mass spectrometry to verify the exact composition of the duplex. Each lot is compared to the previous lot by mass spectrometry to ensure maximum lot-to-lot consistency.
Directions for Use: We recommends transfection with 100 nM siRNA 48 to 72 hours prior to cell lysis. Before resuspending, briefly centrifuge the tube to ensure the lyophilized siRNA is at the bottom of the tube. Resuspend the siRNA oligos to an appropriate concentration with DEPC water. For each vial, suitable for 250 transfections in 24 well plate (20 pmol for each well).
Components: We offer pre-designed sets of 3 different target-specific siRNA oligo duplexes of human TRAT1 gene. Each vial contains 5 nmol of lyophilized siRNA. The duplexes can be transfected individually or pooled together to achieve knockdown of the target gene, which is most commonly assessed by qPCR or western blot. Our siRNA oligos are also chemically modified (2\'-OMe) at no extra charge for increased stability and enhanced knockdown in vitro and in vivo. Blood tissues are correlated with this protein. The following patways have been known to be associated with this gene. TRAT1 also interacts with the following gene(s): CD3D, CD4, CD8A, ZAP70.
horiz bar
 SSL   Follow us on Facebook Follow us onTwitter Follow us on Google Plus Connect us on LinkedIn Subscribe to our RSS Feed for latest products and special promotions